{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:36:24Z","timestamp":1787243784857,"version":"build-2736575974"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,7,2]],"date-time":"2016-07-02T00:00:00Z","timestamp":1467417600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s12016-016-8562-7","type":"journal-article","created":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T21:09:06Z","timestamp":1467407346000},"page":"182-193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Review of Mouse Models of Graves\u2019 Disease and Orbitopathy\u2014Novel Treatment by Induction of Tolerance"],"prefix":"10.1007","volume":"52","author":[{"given":"Martin","family":"Ungerer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Fa\u00dfbender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6tz","family":"M\u00fcnch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Holthoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,2]]},"reference":[{"key":"8562_CR1","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJM200010263431707","volume":"34","author":"AP Weetman","year":"2000","unstructured":"Weetman AP (2000) Graves\u2019 disease. N Engl J Med 34:1236\u20131248","journal-title":"N Engl J Med"},{"key":"8562_CR2","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1089\/thy.2005.15.1279","volume":"15","author":"M Abraham-Nordling","year":"2005","unstructured":"Abraham-Nordling M, T\u00f6rring O, Hamberger B, Lundell G, Tallstedt L, Calissendorf J, Wallin G (2005) Graves\u2019 disease: a long-term quality of life follow up of patients randomized to treatment with antithyroid drugs, radioiodine or surgery. Thyroid 15:1279\u20131285","journal-title":"Thyroid"},{"key":"8562_CR3","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1210\/er.2004-0023","volume":"26","author":"SM McLachlan","year":"2005","unstructured":"McLachlan SM, Nagayama Y, Rapoport B (2005) Insight into Graves\u2019 hyperthyroidism from animal models. Endocr Rev 26:800\u2013832","journal-title":"Endocr Rev"},{"key":"8562_CR4","doi-asserted-by":"crossref","first-page":"11074","DOI":"10.1073\/pnas.93.20.11074","volume":"93","author":"N Shimojo","year":"1996","unstructured":"Shimojo N, Kohno Y, Yamaguchi KI, Kikuoka SI, Hoshioka A, Niimi H, Hirai A, Tamura Y, Saito Y, Kohn LD, Tahara K (1996) Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyreotropin receptor and a class II molecule. Proc Natl Acad Sci 93:11074\u201311079","journal-title":"Proc Natl Acad Sci"},{"key":"8562_CR5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1046\/j.1365-2249.2003.02080.x","volume":"131","author":"M Kita-Furayama","year":"2003","unstructured":"Kita-Furayama M, Nagayama Y, Pichurin P, McLachlan SM, Rapoport B, Eguchi K (2003) Dendritic cells infected with adenovirus expressing the thyreotropin receptor induce Graves\u2019 hyperthyroidism in BALB\/c mice. Clin Exp Immunol 131:234\u2013240","journal-title":"Clin Exp Immunol"},{"key":"8562_CR6","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.4049\/jimmunol.168.6.2789","volume":"168","author":"Y Nagayama","year":"2002","unstructured":"Nagayama Y, Kita-Furuyama M, Ando T, Nakao K, Mizuiguchi H, Hayakawa T, Eguchi K, Niwa M (2002) A novel murine model of Graves\u2019 hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor. J Immunol 168:2789\u20132794","journal-title":"J Immunol"},{"key":"8562_CR7","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1089\/thy.2007.0161","volume":"\u115f","author":"Y Nagayama","year":"2007","unstructured":"Nagayama Y (2007) Graves\u2019 animal models of Graves\u2019 hyperthyroidism. Thyroid \u115f:981\u2013988","journal-title":"Thyroid"},{"key":"8562_CR8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1530\/JOE-11-0162","volume":"210","author":"SX Zhao","year":"2011","unstructured":"Zhao SX, Tsui S, Cheung A, Douglas RS, Smith TJ, Banga JP (2011) Orbital fibrosis in a mouse model of Graves\u2019 disease induced by genetic immunization of thyrotropin receptor cDNA. J Endocrinol 210:369\u2013377","journal-title":"J Endocrinol"},{"issue":"9","key":"8562_CR9","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1210\/en.2013-1576","volume":"154","author":"S Moshkelgosha","year":"2013","unstructured":"Moshkelgosha S, So PW, Deasy N, Diaz-Cano S, Banga JP (2013) Retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves\u2019 orbitopathy induced by thyrotropin receptor plasmid in vivo electroporation. Endocrinology 154(9):3008\u20133015","journal-title":"Endocrinology"},{"key":"8562_CR10","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1210\/en.2006-1077","volume":"148","author":"T Kaneda","year":"2007","unstructured":"Kaneda T, Honda A, Hakozaki A, Fuse T, Muto A, Yoshida T (2007) An improved Graves\u2019 disease model established by using in vivo electroporation exhibited long-term immunity to hyperthyroidism in BALB\/c mice. Endocrinology 148:2335\u20132344","journal-title":"Endocrinology"},{"key":"8562_CR11","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1172\/JCI200317069","volume":"111","author":"CR Chen","year":"2003","unstructured":"Chen CR, Pichurin P, Nagayama Y, Latrofa F, McLachlan SM, Rapoport B (2003) The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim. J Clin Invest 111:1897\u20131904","journal-title":"J Clin Invest"},{"key":"8562_CR12","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1210\/en.2003-1134","volume":"145","author":"CR Chen","year":"2004","unstructured":"Chen CR, Pichurin P, Chazenbalk GD, Aliesky H, Nagayama Y, McLachlan SM, Rapoport B (2004) Low dose immunization with adenovirus expressing the thyroid-stimulating hormone receptor A subunit deviates the antibody response toward that of autoantibodies in human Graves disease. Endocrinology 145:228\u2013233","journal-title":"Endocrinology"},{"key":"8562_CR13","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1089\/thy.2012.0008","volume":"9","author":"SM McLachlan","year":"2012","unstructured":"McLachlan SM, Aliesky H, Chen CR, Rapoport B (2012) Role of self tolerance and chronic stimulation in the long term persistence of adenovirus-induced thyrotropin receptor antibodies in wild-type and transgeneic mice. Thyroid 9:931\u2013937","journal-title":"Thyroid"},{"issue":"9","key":"8562_CR14","doi-asserted-by":"crossref","first-page":"e43517","DOI":"10.1371\/journal.pone.0043517","volume":"7","author":"SM McLachlan","year":"2012","unstructured":"McLachlan SM, Aliesky H, Chen CR, Chong G, Rapoport B (2012) Breaking tolerance in transgenic mice expressing the human TSH receptor A subunit: thyroiditis, epitope spreading and adjuvant as a \u201cdouble edged sword\u201d. PLoS One 7(9):e43517","journal-title":"PLoS One"},{"key":"8562_CR15","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1210\/en.2014-1813","volume":"156","author":"HP Holthoff","year":"2015","unstructured":"Holthoff HP, G\u00f6bel S, Li ZM, Fassbender J, Reimann A, Zeibig S, Lohse MJ, M\u00fcnch G, Ungerer M (2015) Prolonged TSH receptor A subunit immunization of female mice leads to a long-term model of Graves\u2019 disease, tachycardia and cardiac hypertrophy. Endocrinology 156:1577\u20131589","journal-title":"Endocrinology"},{"key":"8562_CR16","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1172\/JCI200420149","volume":"113","author":"R Jahns","year":"2004","unstructured":"Jahns R, Boivin V, Hein L, Triebel S, Angermann CE, Ertl G, Lohse MJ (2004) Direct evidence for a \u00df1-adrenergic receptor directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 113:1419\u20131429","journal-title":"J Clin Invest"},{"key":"8562_CR17","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1172\/JCI21748","volume":"113","author":"NJ Freedman","year":"2004","unstructured":"Freedman NJ, Lefkowitz RJ (2004) Anti-\u00df1-adrenergic receptor antibodies and heart failure: causation, not just correlation. J Clin Invest 113:1379\u20131382","journal-title":"J Clin Invest"},{"key":"8562_CR18","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1507\/endocrj.52.525","volume":"52","author":"K Kamijo","year":"2005","unstructured":"Kamijo K, Ishikawa K, Tanaka M (2005) Clinical evaluation of 3rd generation assay for thyrotropin receptor antibodies: the M22-biotin-based ELISA initiated by Smith. Endocr J 52:525\u2013529","journal-title":"Endocr J"},{"key":"8562_CR19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.autrev.2012.07.003","volume":"12","author":"R Tozzoli","year":"2012","unstructured":"Tozzoli R, Bagnasco M, Giavarina D, Bizzaro N (2012) TSH receptor autoantibody immunoassay in patients with Graves\u2019 disease : improvement of diagnostic accuracy over different generations and methods. Systematic review and meta-analysis. Autoimmun Rev 12:107\u2013113","journal-title":"Autoimmun Rev"},{"key":"8562_CR20","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1055\/s-0035-1555956","volume":"47","author":"JP Banga","year":"2015","unstructured":"Banga JP, Moshkelgosha S, Berchner-Pfannschmidt U, Eckstein A (2015) Modelling Graves\u2019 orbitopathy in experimental Graves\u2019 disease. Horm Metab Res 47:797\u2013803","journal-title":"Horm Metab Res"},{"key":"8562_CR21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1440-1746.2004.03183.x","volume":"19","author":"GM Dahab","year":"2004","unstructured":"Dahab GM, Kheriza MM, EL-Beltagi HM, Fouda AMM, Sharaf El-Din OA (2004) Digital quantification of fibrosis in liver biopsy sections: description of a new method by Photoshop software. J Gastroenterol Hepatol 19:78\u201385","journal-title":"J Gastroenterol Hepatol"},{"key":"8562_CR22","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM200105103441901","volume":"344","author":"I Klein","year":"2001","unstructured":"Klein I, Ojamaa K (2001) Thyroid hormone and the cardiovascular system. N Engl J Med 344:501\u2013509","journal-title":"N Engl J Med"},{"key":"8562_CR23","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/0002-9149(89)90142-2","volume":"63","author":"K Olshausen von","year":"1989","unstructured":"von Olshausen K, Bischoff S, Kahaly G, Mohr-Kahaly S, Erbel R, Beyer J, Meyer J (1989) Cardiac arrhythmias and heart rate in hyperthyroidism. Am J Cardiol 63:930\u2013933","journal-title":"Am J Cardiol"},{"key":"8562_CR24","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1210\/jc.2005-1833","volume":"91","author":"RW Flynn","year":"2006","unstructured":"Flynn RW, MacDonald TM, Jung TR, Morris AD, Leese GP (2006) Mortality and vascular outcomes in patients treated for thyroid dysfunction. J Clin Endocrinol Metab 91:2159\u20132164","journal-title":"J Clin Endocrinol Metab"},{"key":"8562_CR25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jacc.2006.08.042","volume":"49","author":"F Osman","year":"2007","unstructured":"Osman F, Franklyn J, Holder RL, Sheppard MC, Gammage MD (2007) Cardiovascular manifestations of hyperthyroidism before and after antithyroid therapy: a matched case\u2013control study. J Am Coll Cardiol 49:71\u201381","journal-title":"J Am Coll Cardiol"},{"key":"8562_CR26","doi-asserted-by":"crossref","first-page":"832","DOI":"10.7326\/0003-4819-148-11-200806030-00225","volume":"148","author":"N Ochs","year":"2008","unstructured":"Ochs N, Auer R, Bauer DC, Nanchen D, Gussekloo J, Cornuz J, Rodondi N (2008) Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med 148:832\u2013845","journal-title":"Ann Intern Med"},{"key":"8562_CR27","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1530\/EJE-09-0845","volume":"162","author":"J Sgarbi","year":"2010","unstructured":"Sgarbi J, Matsumura L, Kasamatsu T, Ferreira S, Maciel R (2010) Subclinical thyroid dysfunctions are independent risk factors for mortality in a 7.5 year follow-up: the Japanese\u2013Brazilian thyroid study. Eur J Endocrinol 162:569\u2013577","journal-title":"Eur J Endocrinol"},{"key":"8562_CR28","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nrendo.2010.105","volume":"6","author":"B Biondi","year":"2010","unstructured":"Biondi B, Kahaly GJ (2010) Cardiovascular involvement in patients with different causes of hyperthyroidism. Nat Rev Endocrinol 6:431\u2013443","journal-title":"Nat Rev Endocrinol"},{"key":"8562_CR29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1530\/JOE-13-0279","volume":"219","author":"Y Wang","year":"2013","unstructured":"Wang Y, Wu LP, Fu J, Lv HJ, Guan XY, Xu L, Chen P, Gao CQ, Hou P, Ji MJ, Shi BY (2013) Hyperthyroid monkeys: a nonhuman primate model of experimental Graves\u2019 disease. J Endocrinol 219:183\u2013193","journal-title":"J Endocrinol"},{"key":"8562_CR30","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMct1007101","volume":"364","author":"DS Ross","year":"2011","unstructured":"Ross DS (2011) Radioiodine therapy for hyperthyroidism. N Engl J Med 364:542\u2013550","journal-title":"N Engl J Med"},{"key":"8562_CR31","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1210\/jc.2013-1954","volume":"98","author":"V Sundaresh","year":"2013","unstructured":"Sundaresh V, Brito JP, Wang Z, Prokop LJ, Stan MN, Murad MH, Bahn RS (2013) Comparative effectiveness of therapies for Graves\u2019 hyperthyroidism: a systematic review and network meta analysis. J Clin Endocrinol Metab 98:3671\u20133677","journal-title":"J Clin Endocrinol Metab"},{"key":"8562_CR32","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","volume":"362","author":"RS Bahn","year":"2010","unstructured":"Bahn RS (2010) Graves\u2019 ophthalmopathy. N Engl J Med 362:726\u2013738","journal-title":"N Engl J Med"},{"key":"8562_CR33","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1210\/jc.2014-2572","volume":"100","author":"MN Stan","year":"2015","unstructured":"Stan MN, Garrity JA, Carranza Leon BG, Prabin T, Bradley EA, Bahn RS (2015) Randomized Controlled Trial of Rituximab in Patients With Graves\u2019 Orbitopathy. J Clin Endocrinol Metabol 100:432\u2013441","journal-title":"J Clin Endocrinol Metabol"},{"key":"8562_CR34","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1210\/jc.2014-3014","volume":"100","author":"M Salvi","year":"2015","unstructured":"Salvi M, Vannucchi G, Curro N, Campi I, Covelli D, Dazzi D, Simonetta S, Guastella C, Pignataro L, Avignone S, Beck-Peccoz P (2015) Efficacy of B cell targeted therapy with rituximab in patients with active moderate \u2013 severe Graves\u2019 oritopathy: a randiomized controlled study. J Clin Endocrinol Metab 100:422\u2013431","journal-title":"J Clin Endocrinol Metab"},{"key":"8562_CR35","first-page":"309","volume":"163","author":"I Ueki","year":"2011","unstructured":"Ueki I, Abiru N, Kobayashi M, Nakahara M, Ichikawa T, Eguchi K, Nagayama Y (2011) B cell targeted therapy with anti-CD20 monoclonal antibody in a mouse model of Graves\u2019 hyperthyroidism. J Translat Immunol 163:309\u2013317","journal-title":"J Translat Immunol"},{"key":"8562_CR36","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1210\/en.2006-0507","volume":"147","author":"JA Gilbert","year":"2006","unstructured":"Gilbert JA, Kalled SL, Moorhead J, Hess DM, Rennert P, Li Z, Khan MZ, Banga JP (2006) Treatment of autoimmune hyperthyroidism in a murine model of Graves\u2019 disease with TNF family ligand inhibitors suggests a key role for B cell activating factor in disease pathology. Endocrinology 147:4561\u20134568","journal-title":"Endocrinology"},{"key":"8562_CR37","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrd2085","volume":"5","author":"JL Browning","year":"2006","unstructured":"Browning JL (2006) B cells move to center stage: novel opportunities for autoimmune disease treatment. Nat Rev Drug Discov 5:564\u2013576","journal-title":"Nat Rev Drug Discov"},{"key":"8562_CR38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jaut.2007.02.001","volume":"28","author":"M Blank","year":"2007","unstructured":"Blank M, Shoenfeld Y (2007) B cell targeted therapy in autoimmunity. J Autoimmunity 28:62\u201368","journal-title":"J Autoimmunity"},{"key":"8562_CR39","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1055\/s-0035-1559648","volume":"47","author":"J Furmaniak","year":"2015","unstructured":"Furmaniak J, Sanders J, Nunez Miguel R, Rees Smith B (2015) Mechanism of action of TSHR autoantibodies. Horm Metab Res 47:735\u2013752","journal-title":"Horm Metab Res"},{"key":"8562_CR40","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1210\/jc.2010-1935","volume":"96","author":"S Neumann","year":"2011","unstructured":"Neumann S, Eliseeva E, McCoy J, Napolitano G, Giuliani C, Monaco F, Huang W, Gershengorn MC (2011) A new small molecule antagonist inhibits Graves\u2019 disease antibody activation of the TSH receptor. J Clin Endocrin Metabol 96:548\u2013554","journal-title":"J Clin Endocrin Metabol"},{"key":"8562_CR41","doi-asserted-by":"crossref","first-page":"E781","DOI":"10.1210\/jc.2011-2931","volume":"97","author":"CJJJ Zeijl van","year":"2012","unstructured":"van Zeijl CJJJ, van Koppen CJ, Surotseva O, de Gooyer ME, Plate R, Conti P, Karstens WJ, Timmers M, Saeed P, Wiersinga WM, Miltenburg AMM, Fliers E, Boelen A (2012) Complete inhibition of rhTSH-, Graves\u2019 disease IgG- and M22-induced cAMP production in differentiated orbital fibroblasts by a low molecular weight TSHR antagonist. J Clin Endocrinol Metabol 97:E781\u2013E785","journal-title":"J Clin Endocrinol Metabol"},{"key":"8562_CR42","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1055\/s-0035-1555901","volume":"47","author":"S Neumann","year":"2015","unstructured":"Neumann S, Place RF, Krieger CC, Gershengorn MC (2015) Future prospects for the treatment of Graves\u2019 hyperthyroidism and eye disease. Horm Metab Res 47:789\u2013796","journal-title":"Horm Metab Res"},{"issue":"4","key":"8562_CR43","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1038\/nm1226","volume":"11","author":"M Larche","year":"2005","unstructured":"Larche M, Wraith DC (2005) Peptide-based therapeutic vaccines for allergic and autoimmune diseases. Nat Med 11(4):S69\u2013S76","journal-title":"Nat Med"},{"key":"8562_CR44","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1378\/chest.14-0049","volume":"146","author":"M Soyka","year":"2014","unstructured":"Soyka M, van de Veen W, Holzmann D, Akdis M, Akdis CA (2014) Scientific foundations of allergen-specific immunotherapy for allergic diseases. Chest 146:1347\u20131357","journal-title":"Chest"},{"key":"8562_CR45","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev-immunol-030409-101218","volume":"28","author":"R Valenta","year":"2010","unstructured":"Valenta R, Ferreira F, Focke-Tejkl M, Linhart B, Niederberger V, Swoboda I, Vrtala S (2010) From allergen genes to allergy vaccines. Ann Rev Immunol 28:211\u2013241","journal-title":"Ann Rev Immunol"},{"key":"8562_CR46","isbn-type":"print","first-page":"162","volume-title":"Janeways\u2019s immunobiology","author":"K Murphy","year":"2008","unstructured":"Murphy K, Travers P, Walport M (2008) Janeways\u2019s immunobiology. Garland Science Editors, New York, pp 162\u2013194. ISBN 0-8153-4123-7","ISBN":"https:\/\/id.crossref.org\/isbn\/0815341237"},{"key":"8562_CR47","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri823","volume":"2","author":"AG Baxter","year":"2002","unstructured":"Baxter AG, Hodgkin PD (2002) Activation rules: the two-signal theories of immune activation. Nat Rev Immunol 2:429\u2013446","journal-title":"Nat Rev Immunol"},{"key":"8562_CR48","isbn-type":"print","first-page":"347","volume-title":"Janeways\u2019s immunobiology","author":"K Murphy","year":"2008","unstructured":"Murphy K, Travers P, Walport M (2008) Janeways\u2019s immunobiology. Garland Science Editors, New York, pp 347\u2013348. ISBN 0-8153-4123-7","ISBN":"https:\/\/id.crossref.org\/isbn\/0815341237"},{"key":"8562_CR49","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/nature17300","volume":"530","author":"DC Wraith","year":"2016","unstructured":"Wraith DC (2016) Antigen-specific immunotherapy. Nature 530:422\u2013423","journal-title":"Nature"},{"key":"8562_CR50","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nature16962","volume":"530","author":"X Clemente-Casares","year":"2016","unstructured":"Clemente-Casares X, Blanco J, Ambalavanan P, Yamanouchi J, Singha S, Fandos C, Tsai S, Wang J, Garabatos N, Izquierdo C, Agrawal S, Keough MB, Yong VW, James E, Moore A, Yang Y, Stratmann T, Serra P, Santamaria P (2016) Expanding antigen-specific regulatory networks to treat autoimmunity. Nature 530:434\u2013440","journal-title":"Nature"},{"key":"8562_CR51","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2174\/156652406778194982","volume":"6","author":"K Hochweller","year":"2006","unstructured":"Hochweller K, Sweenie CH, Anderton SM (2006) Immunological tolerance using synthetic peptides \u2013 basic mechanisms and clinical applications. Curr Mol Med 6:631\u2013643","journal-title":"Curr Mol Med"},{"key":"8562_CR52","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1038\/ncomms5741","volume":"5","author":"BR Burton","year":"2014","unstructured":"Burton BR, Britton GJ, Fang H, Verhagen J, Smithers B, Sabto-Peyton CA, Carney L, Gough J, Strobel S, Wraith DC (2014) Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy. Nat Commun 5:4741. doi: 10.1038\/ncomms5741","journal-title":"Nat Commun"},{"key":"8562_CR53","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.coi.2010.08.006","volume":"22","author":"CA Sabatos-Peyton","year":"2010","unstructured":"Sabatos-Peyton CA, Verhagen J, Wraith DC (2010) Antigen-specific immunotherapy of autoimmune and allergic diseases. Curr Opin Immunol 22:609\u2013615","journal-title":"Curr Opin Immunol"},{"key":"8562_CR54","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri724","volume":"2","author":"CL Vanderlught","year":"2002","unstructured":"Vanderlught CL, Miller SD (2002) Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat Rev Immunol 2:85\u201395","journal-title":"Nat Rev Immunol"},{"key":"8562_CR55","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm0710-740","volume":"7","author":"E Dolgin","year":"2010","unstructured":"Dolgin E (2010) The inverse of immunity. Nat Med 7:740\u2013743","journal-title":"Nat Med"},{"key":"8562_CR56","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/507418a","volume":"507","author":"K Garber","year":"2014","unstructured":"Garber K (2014) A tolerant approach. Nature 507:418\u2013420","journal-title":"Nature"},{"issue":"2","key":"8562_CR57","doi-asserted-by":"publisher","first-page":"e0117589","DOI":"10.1371\/journal.pone.0117589","volume":"10","author":"V Boivin","year":"2015","unstructured":"Boivin V, Beyersdorf N, Palm D, Nikolaev VO, Schlipp A, M\u00fcller J, Schmidt D, Kokoski V, Kerkau T, H\u00fcnig T, Ertl G, Lohse MJ, Jahns R (2015) Novel receptor-derived cyclopeptides to treat heart failure caused by anti-\u03b21-adrenoceptor antibodies in a human-analogous rat model. PLoS One 10(2):e0117589. doi: 10.1371\/journal.pone.0117589","journal-title":"PLoS One"},{"key":"8562_CR58","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/eurjhf\/hfs118","volume":"14","author":"G M\u00fcnch","year":"2012","unstructured":"M\u00fcnch G, Boivin-Jahns V, Holthoff HP, Adler K, Lappo M, Tru\u00f6l S, Degen H, Steiger N, Lohse MJ, Jahns R, Ungerer M (2012) Administration of the cyclic peptide COR-1 (phase I study): ex vivo measurements of anti-\u00df1 receptor antibody neutralization and of immune parameters. Eur J Heart Fail 14:1230\u20131239","journal-title":"Eur J Heart Fail"},{"key":"8562_CR59","doi-asserted-by":"crossref","unstructured":"St\u00f6rk S, Plotnikov AN, Peters G, Davies BE, Nnane I, Rivas D, Tesfaye F, K\u00e4\u00e4b S, Bauer A, Luchner A, Ungerer M, Jahns R, Lohse MJ, Ertl G (2016) Effects of JNJ-54452840, an anti-\u00df1 receptor antibody cyclopeptide in heart failure patients: a randomized, double-blind, parallel-group, phase-2 pilot study. Submitted","DOI":"10.4172\/2329-6607.1000190"},{"key":"8562_CR60","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1073\/pnas.79.6.2013","volume":"79","author":"BL Pike","year":"1982","unstructured":"Pike BL, Boyd AW, Nossal GJV (1982) Clonal anergy: the universally anergic B lymphocyte. Proc Natl Acad Sci U S A 79:2013\u20132017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8562_CR61","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.coi.2006.03.015","volume":"18","author":"SB Gauld","year":"2011","unstructured":"Gauld SB, Merell KT, Cambier JC (2011) Silencing of autoreactive B cells in anergy: a fresh perspective. Curr Opin Immunol 18:292\u2013297","journal-title":"Curr Opin Immunol"},{"issue":"24","key":"8562_CR62","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1182\/blood-2009-09-243071","volume":"115","author":"I Isnardi","year":"2010","unstructured":"Isnardi I, Ng YS, Menard L, Meyers G, Saadoun D, Srdanovic I, Samuels J, Berman J, Buckner JH, Cunningham-Rundles C, Meffre E (2010) Complement receptor 2\/CD21- human naive B cells contain mostly autoreactive unresponsive clones. Blood 115(24):5026\u20135036","journal-title":"Blood"},{"key":"8562_CR63","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1182\/blood-2010-03-276352","volume":"115","author":"S Andrews","year":"2010","unstructured":"Andrews S, Wilson PC (2010) The anergic B cell. Blood 115:4974\u20134978","journal-title":"Blood"},{"key":"8562_CR64","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nature11311","volume":"489","author":"J Zikherman","year":"2012","unstructured":"Zikherman J, Paraweswaran R, Weiss A (2012) Endogenous antigen tunes the responsiveness of na\u00efve B cells but not T cells. Nature 489:160\u2013164","journal-title":"Nature"},{"key":"8562_CR65","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.clim.2007.11.007","volume":"127","author":"T Arima","year":"2007","unstructured":"Arima T, Shimojo N, Yamaguchi KI, Tomiita M, Kohn LD, Kohnoi Y (2007) Enhancement of experimental Graves\u2019 disease by intranasal administration of a T cell epitope of the thyrotropin receptor. Clin Immunol 127:7\u201313","journal-title":"Clin Immunol"},{"key":"8562_CR66","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1210\/en.2009-0181","volume":"150","author":"AV Misharin","year":"2009","unstructured":"Misharin AV, Nagayama Y, Aliesky HA, Mituzori Y, Rapoport B, McLachlan SM (2009) Attenuation of induced hyperthyroidism in mice by pretreatment with thyrotropin receptor protein: deviation of thyroid-stimulating to non-functional antibodies. Endocrinology 150:3944\u20133952","journal-title":"Endocrinology"},{"key":"8562_CR67","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1210\/en.2010-0737","volume":"152","author":"LP Wu","year":"2011","unstructured":"Wu LP, Xun L, Yang J, Tian Z, Gao S, Zhang Y, Hou P, Shi B (2011) Induction of murine neonatal tolerance against Graves\u2019 disease using recombinant adenovirus expressing the TSH receptor A subunit. Endocrinology 152:1165\u20131171","journal-title":"Endocrinology"},{"key":"8562_CR68","unstructured":"Vrolix K, Feyaerts D, Jahraus A, Jansson L, Wraith DC. Antigen-specific peptide therapy prevents formation of TSHR-antibodies in HLA-DR transgenic mice. Retrieved from http:\/\/www.daviad.eu\/knowledge-for-growth-may-21st-2015-ghent-belgium . Accessed 20 March 2016"},{"key":"8562_CR69","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1172\/JCI7665","volume":"105","author":"S Costagliola","year":"2000","unstructured":"Costagliola S, Many MC, Denef JF, Pohlenz J, Refetoff S, Vassart G (2000) Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves\u2019 disease. J Clin Invest 105:803\u2013811","journal-title":"J Clin Invest"},{"issue":"6","key":"8562_CR70","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/0891693021000026319","volume":"35","author":"M Yamada","year":"2002","unstructured":"Yamada M, Li AW, West KA, Chang CH, Wall JR (2002) Experimental model for ophthalmopathy in BALB\/c and outbred (CD-1) mice genetically immunized with G2s and the thyrotropin receptor. Autoimmunity 35(6):403\u2013413","journal-title":"Autoimmunity"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-016-8562-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-016-8562-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-016-8562-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-016-8562-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T11:37:12Z","timestamp":1568115432000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-016-8562-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,2]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["8562"],"URL":"https:\/\/doi.org\/10.1007\/s12016-016-8562-7","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,2]]}}}